中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 9
Sep.  2017
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2017  >  33(9): 1646-1654

Expert consensus on the optimization of perioperative management of liver transplantation for severe hepatitis by enhanced recovery after surgery

DOI: 10.3969/j.issn.1001-5256.2017.09.005
Research funding:

 

  • Published Date: 2017-09-20
    Abstract

  • In order to apply the concept of enhanced recovery after surgery ( ERAS) in the optimization of perioperative management of liver transplantation for severe hepatitis, reduce complications, and promote patients'fast recovery, Study Group of Transplantation Immunology, Society of Organ Transplantation, Chinese Medical Doctor Association, Study Group of Surgery, Chinese Society of Surgery, Chinese Medical Association, and Society of Organ Transplantation, Guangdong Medical Doctor Association have developed Expert consensus on the optimization of perioperative management of liver transplantation for severe hepatitis by enhanced recovery after surgery. This consensus summarizes the clinical experience in each transplantation center from the perspective of the role of ERAS in the optimization of preoperative, intraoperative, and postoperative treatment strategies for liver transplantation for severe hepatitis and puts forward related expert consensus, in order to provide a reference for clinical optimization of perioperative management of liver transplantation for severe hepatitis.

     

    • FullText(HTML)
  • loading
    • References(33)
  • [1]European Association for the Study of the Liver.EASL clinical practice guidelines:liver transplantation[J].J Hepatol, 2016, 64 (2) :433-485.
    [2]SMOTER P, NYCKOWSKI P, GRAT M, et al.Risk factors of acute renal failure after orthotopic liver transplantation:single-center experience[J].Transplant Proc, 2014, 46 (8) :2786-2789.
    [3]KAMAR N, GUILBEAU-FRUGIER C, SERVAIS A, et al.Kidney histology and function in liver transplant patients[J].Nephrol Dial Transplant, 2011, 26 (7) :2355-2361.
    [4]MPABANZI L, JALAN R.Neurological complications of acute liver failure:pathophysiological basis of current management and emerging therapies[J].Neurochem Int, 2012, 60 (7) :736-742.
    [5]PLANK LD, MATHUR S, GANE EJ, et al.Perioperative immunonutrition in patients undergoing liver transplantation:a randomized double-blind trial[J].Hepatology, 2015, 61 (2) :639-647.
    [6]VERA A, CONTRERAS F, GUEVARA F.Incidence and risk factors for infections after liver transplant:single-center experience at the University Hospital Fundación Santa Fe de Bogotá, Colombia[J].Transpl Infect Dis, 2011, 13 (6) :608-615.
    [7]DALAL A.Anesthesia for liver transplantation[J].Transplant Rev (Orlando) , 2016, 30 (1) :51-60.
    [8]LI M, ZHANG LP, YANG L.Fluids administration and coagulation characteristics in patients with different model for end-stage liver disease scores undergoing orthotopic liver transplantation[J].Chin Med J (Engl) , 2007, 120 (22) :1963-1968.
    [9]CHENG XS, TAN JC, KIM WR.Management of renal failure in end-stage liver disease:a critical appraisal[J].Liver Transpl, 2016, 22 (12) :1710-1719.
    [10]CAVALLIN M, KAMATH PS, MERLI M, et al.Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome:a randomized trial[J].Hepatology, 2015, 62 (2) :567-574.
    [11]LEISE MD, YUN BC, LARSON JJ, et al.Effect of the pretransplant serum sodium concentration on outcomes following liver transplantation[J].Liver Transpl, 2014, 20 (6) :687-697.
    [12]LAISH I, BRAUN M, MOR E, et al.Metabolic syndrome in liver transplant recipients:prevalence, risk factors, and association with cardiovascular events[J].Liver Transpl, 2011, 17 (1) :15-22.
    [13]SCHUMANN R, MANDELL MS, MERCALDO N, et al.Anesthesia for liver transplantation in United States academic centers:intraoperative practice[J].J Clin Anesth, 2013, 25 (7) :542-550.
    [14]FAYED N, REFAAT EK, YASSEIN TE, et al.Effect of perioperative terlipressin infusion on systemic, hepatic, and renal hemodynamics during living donor liver transplantation[J].J Crit Care, 2013, 28 (5) :775-782.
    [15]MUKHTAR A, SALAH M, ABOULFETOUH F, et al.The use of terlipressin during living donor liver transplantation:effects on systemic and splanchnic hemodynamics and renal function[J].Crit Care Med, 2011, 39 (6) :1329-1334.
    [16]LIU LL, NIEMANN CU.Intraoperative management of liver transplant patients[J].Transplant Rev (Orlando) , 2011, 25 (3) :124-129.
    [17]HAN HY, WEN SL.Quality of life and psychological intervention after liver transplant patients[J].Organ Transplant, 2013, 4 (3) :177-181. (in Chinese) 韩洪瀛, 温盛霖.肝移植患者术后生存质量及心理干预[J].器官移植, 2013, 4 (3) :177-181.
    [18]ERRICHIELLO L, PICOZZI D, de NOTARIS EB.Prevalence of psychiatric disorders and suicidal ideation in liver transplanted patients:a cross-sectional study[J].Clin Res Hepatol Gastroenterol, 2014, 38 (1) :55-62.
    [19]DUAN M.The analyze of potential risk factors of postoperative pulmonary infection in patients undergoing liver transplantation[J].Chin J Nurs, 2002, 37 (8) :574-576. (in Chinese) 段敏.肝脏移植患者术后肺部感染的危险因素分析[J].中华护理杂志, 2002, 37 (8) :574-576.
    [20]SNOWDEN CP, HUGHES T, ROSE J, et al.Pulmonary edema in patients after liver transplantation[J].Liver Transpl, 2000, 6 (4) :466-470.
    [21]YANG L, ZHANG H, NIU LJ, et al.Analysis of related risk factors of early acute renal failure after orthotopic liver transplantation[J].J Pract Med, 2010, 26 (9) :1584-1586. (in Chinese) 杨璐, 张辉, 牛丽君, 等.肝移植术后早期急性肾功能衰竭的相关危险因素分析[J].实用医学杂志, 2010, 26 (9) :1584-1586.
    [22]Surgery Branch Organ Transplantation Group of Chinese Medical Association.Guideline for diagnosis and treatment of renal function injury in liver transplant recipients[J/CD].Pract J Organ Transplant:Electr Vers, 2013, 1 (2) :72-74. (in Chinese) 中华医学会外科学分会器官移植学组.肝移植受者肾功能损伤诊疗指南[J/CD].实用器官移植电子杂志, 2013, 1 (2) :72-74.
    [23]PEDERSEN M, SEETHARAM A.Infections after orthotopic liver transplantation[J].J Clin Exp Hepatol, 2014, 4 (4) :347-360.
    [24]ROMERO FA, RAZONABLE RR.Infections in liver transplant recipients[J].World J Hepatol, 2011, 3 (4) :83-92.
    [25]YI HM, CAI CJ, LU MQ, et al.The treatment strategy of early ALIafter liver transplantation[J].Chin J Surg, 2006, 44 (13) :889-893. (in Chinese) 易慧敏, 蔡常洁, 陆敏强, 等.肝移植术后急性肺损伤的治疗策略[J].中华外科杂志, 2006, 44 (13) :889-893.
    [26]TAHA AM, SHARIF K, JOHNSON T, et al.Long-term outcomes of isolated liver transplantation for short bowel syndrome and intestinal failure-associated liver disease[J].J Pediatr Gastroenterol Nutr, 2012, 54 (4) :547-551.
    [27]BINHAS M, AMATHIEU R, CAMPILLO B, et al.French survey on perioperative nutrition in cirrhotic adult patients waiting for liver transplantation[J].Ann Fr Anesth Reanim, 2013, 32 (5) :302-306.
    [28]PENG S, LU Y.Clinical epidemiology of central venous catheterrelated bloodstream infections in an intensive care unit in China[J].J Crit Care, 2013, 28 (3) :277-283.
    [29]LIU P.Postoperative nursing of intraperitoneal and biliary T-shaped drainage tubes after liver transplantation[J].J Clin Nurs, 2006, 5 (4) :26-27. (in Chinese) 刘萍.肝移植术后腹腔和胆道T型引流管的术后护理[J].临床护理杂志, 2006, 5 (4) :26-27.
    [30]FAN Y, ZHUANG L, LU H, et al.Application value of fast-track surgery on liver transplantation[J].Organ Transplant, 2014, 5 (6) :348-351, 376. (in Chinese) 范烨, 壮麟, 鲁皓, 等.快速康复外科治疗在肝移植中的应用价值[J].器官移植, 2014, 5 (6) :348-351, 376.
    [31]HALAWA A, BOYES S, ROBERTS F, et al.Challenging the old traditions in renal transplantation:enhanced recovery after renal transplantation[J].Transpl Int, 2011, 24 (Suppl 2) :339.
    [32]KERWIN AJ, NUSSBAUM MS.Adjuvant nutrition management of patients with liver failure, including transplant[J].Surg Clin North Am, 2011, 91 (3) :565-578.
    [33]WIESNER RH, FUNG JJ.Present state of immunosuppressive therapy in liver transplant recipients[J].Liver Transpl, 2011, 17 (Suppl 3) :s1-s9.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (2461) PDF downloads(488) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return